Advertisement
U.S. markets close in 5 hours 21 minutes

Aura Biosciences, Inc. (AURA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
9.17+0.22 (+2.46%)
As of 10:37AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close8.95
Open9.00
Bid9.11 x 200
Ask9.25 x 200
Day's Range9.00 - 9.17
52 Week Range6.63 - 12.38
Volume70,716
Avg. Volume190,740
Market Cap458.055M
Beta (5Y Monthly)0.33
PE Ratio (TTM)N/A
EPS (TTM)-1.73
Earnings DateNov 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.43
  • GlobeNewswire

    Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

    Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple Clinical Complete Responses Observed with Single Low Dose of Bel-sar in Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC); Phase 1 Expansion Preparation in Progress Strong Cash Position Expected to Support Operations into 2H 2026 BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences,

  • Simply Wall St.

    One Aura Biosciences Insider Raised Stake By 232% In Previous Year

    From what we can see, insiders were net buyers in Aura Biosciences, Inc.'s ( NASDAQ:AURA ) during the past 12 months...